68 -10 (84) 2025 - Kholikova A.O., Abidova D.Kh. - "ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH ACROMEGALY AND SECONDARY EMPTY SELLA SYNDROME USING THE INTERNATIONAL ACRO-QOL QUESTIONNAIRE"

"ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH ACROMEGALY AND SECONDARY EMPTY SELLA SYNDROME USING THE INTERNATIONAL ACRO-QOL QUESTIONNAIRE"

Kholikova A.O. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Abidova D.Kh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The purpose of the study is to evaluate the quality of life of patients with acromegaly and secondary syndrome of the "empty" Turkish saddle using the Acro-Col questionnaire. Material and research methods. On the basis of the department of neuroendocrinology of the Republican Specialized Scientific and Practical Medical Center for Endocrinology of the MZ RUZ named after Acad. Yo.Kh. Turakulova from 2022 to 2023, 70 patients with acromigaly and subts were examined. Of the 70 sick men, there were 43, women - 27. The average age was 48.4 ± 14.8 years. Results. After 3 and 6 months after the treatment, the parameters of the quality of life of patients with acromigaria, estimated using the Acro-Qol questionnaire, increased in all groups (P <0.005), the most reliable in patients in the Tag group. Conclusions. 1. According to our data, depression was found in 1/3 of patients (up to 28%) with acromegaly, correlated with the female sex and anxiety. Both depression and anxiety make a significant and independent contribution to the deterioration of the quality of life of patients. 2) Our study shows that the assessment and monitoring of the psychological status of patients with acroomegalia using the Acro-Col questionnaire are mandatory in acromigaly, and also represents an inexpensive tool for this assessment.

Keywords: acromigaly, quality of life, acro-qol

First page

373

Last page

377

For citation:Kholikova A.O., Abidova D.Kh. - "ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH ACROMEGALY AND SECONDARY EMPTY SELLA SYNDROME USING THE INTERNATIONAL ACRO-QOL QUESTIONNAIRE"//New Day in Medicine 10(84)2025 373-377 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

1. Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. // Clin Endocrinol (Oxf). 2002;57(2): 251–8. doi: 10.1046/j.1365-2265.2002.01597.x.
2. Webb SM, Badia X, Surinach NL; Spanish AcroQol Study Group. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. // Eur J Endocrinol. 2006;155(2): 269–77. doi: 10.1530/eje.1.02214.
3. Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C, Biermasz NR. Predictors of quality of life in acromegaly: no consensus on biochemical parameters. // Front Endocrinol (Lausanne). 2017;8:40. doi: 10.3389/ fendo.2017.00040.
4. van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol (Oxf). 2008 Jul;69(1):123-8. doi: 10.1111/j.1365-2265.2007.03169.x.
5. Cangiano B, Giusti E, Premoli C, Soranna D, Vitale G, Grottoli S, Cambria V, Mantovani G, Mungari R, Maffei P, Dassie F, Giampietro A, Chiloiro S, Tanda ML, Ippolito S, Cannavò S, Ragonese M, Zambon A, Persani L, Fatti LM, Scacchi M; “PRO-ACRO” study group on Motor Disability in Acromegaly, of the Italian Society of Endocrinology (SIE). Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine. 2022 Sep;77(3):510-518. doi: 10.1007/s12020-022-03106-8
6. C. Sievers, C. Dimopoulou, H. Pfister et al. Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin. Endocrinol. (Oxf) 71, 691–701 (2009)
7. D.M. Szczesniak, A. Jawiarczyk-Przybylowska, L. Matusiak et al. Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity? Endokrynol. Pol. 2017;68(524–532).
8. E. Karathanasi, M. Poulasouchidou, D. Selalmatzidou et al. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine 47, 564–571 (2014)
9. C. Dimopoulou, S.M. Leistner, M. Ising et al. Body Image Perception in Acromegaly Is Not Associated with Objective Acromegalic Changes but Depends on Depressive Symptoms. Neuroendocrinology 105, 115–122 (2017)
10. J. Tiemensma, A.M. Pereira, J.A. Romijn et al. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: Novel application of the drawing test. Eur. J. Endocrinol. 172, 583–593 (2015)
11. P. Pantanetti, N. Sonino, G. Arnaldi, M. Boscaro, Self Image and Quality of Life in Acromegaly. Pituitary 5, 17–19 (2002)
12. C. Sievers, M. Ising, H. Pfister et al. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur. J. Endocrinol. 160, 367–373 (2009)
13. V.J. Geraedts, C. Dimopoulou, M. Auer et al. Health outcomes in acromegaly: Depression and anxiety are promising targets for improving reduced quality of life. Front Endocrinol. 5, 1–7 (2014)
14. S.M. Webb, L. Prieto, X. Badia et al. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. 57, 251–258 (2002)
15. P.J. Trainer, W.M. Drake, L. Katznelson et al. Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant. N. Engl. J. Med. 342, 1171–1177 (2000)

    file

    download